title: Commentary: Towards an effective and safe treatment of small intestine bacterial overgrowth - Authors' reply.
authors.affiliation: Department of Medicine, Center for Innovation in Access and Quality, San Francisco General Hospital, University of California San Francisco, San Francisco, CA, USA; GI Health, Outcomes, Policy and Economics (GI-HOPE) Program, Division of Gastroenterology, Department of Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, CA, USA. justin.sewell@ucsf.edu.
authors.forename: J L
authors.initials: JL
authors.lastname: Sewell
authors.forename: M
authors.initials: M
authors.lastname: Somsouk
authors.forename: S C
authors.initials: SC
authors.lastname: Shah
authors.forename: L W
authors.initials: LW
authors.lastname: Day
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D006801:Humans; D007421:Intestine, Small / Q000382:microbiology*
chemical_list: D000900:Anti-Bacterial Agents